China to promote centralised medicine procurement, use to ease patients' burden

Xinhuanet

20 November 2019 - China will improve its mechanism for centralized medicine procurement and use in a steady and orderly manner as part of its efforts to deepen healthcare reform and provide better medical services to the people, the State Council decided at its executive meeting chaired by Premier Li Keqiang on Wednesday.

The Chinese government is highly committed to the healthcare reform. Premier Li has demanded unrelenting efforts to advance the pilot centralized medicine procurement and use program so as to significantly ease the financial burden on patients.

The pilot reform, which was launched in April, has already generated notable benefits. It has effectively brought down the price of certain drugs to a rational level, making medication more affordable for the people. The program is now being rolled out nationwide.

Read Xinhuanet article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Market access , China